Haddad, Tufia C. http://orcid.org/0000-0001-8226-3581
D’Assoro, Antonino
Suman, Vera
Opyrchal, Mateusz
Peethambaram, Prema
Liu, Minetta C.
Goetz, Matthew P.
Ingle, James N.
Funding for this research was provided by:
Takeda Pharmaceuticals U.S.A.
National Institutes of Health (K12 CA90628)
National Center for Advancing Translational Sciences (UL1 TR000135)
Article History
Received: 30 November 2017
Accepted: 7 December 2017
First Online: 30 December 2017
Compliance with ethical standards
:
: Dr. Goetz has received research funding Pfizer, Lilly, and Myriad and is a consultant/advisory board member for Lilly, Biotheranostics, and Myriad. Dr. Opyrchal received research funding from Pfizer. The other authors declare no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.